Genertec Universal Medical's Subsidiary Obtains Chinese Regulator Approval for Issuance of 8 Billion Yuan Corporate Bonds

MT Newswires Live01-16

Genertec Universal Medical Group (HKG:2666) said its subsidiary China Universal Leasing obtained the approval from the China Securities Regulatory Commission to issue 8 billion yuan worth of corporate bonds to qualified investors in China, a Thursday Hong Kong bourse filing said.

The corporate bonds, with a balance principal amount of 6.5 billion yuan as of the filing date, will be issued in several tranches on the Shanghai Stock Exchange with the maximum amount set to 600 million yuan for the second tranche of the bonds.

The second tranche of the bonds will have a term of five years and is expected to commence the off-line issuance from Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment